Immune thrombocytopenia (ITP): vizsgálatok itt: Franciaország
18 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 13.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleStudy to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
- Where
- Antony, Creteil, Dijon, Pessac, Toulouse Cedex 9
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- Sanofi
See details and how to joinNCT07007962 · EU 2025-522070-36-00 - 1/2. fázisTaking peopleA Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
- Where
- Creteil Cedex, Dijon, Pessac
- Életkor
- 18 év to 64 év
- People
- 68 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06721013 · EU 2024-518502-40-00 - 3. fázisTaking peopleA Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Where
- Creteil Cedex, Dijon
- Életkor
- 18 év and over
- People
- 171 worldwide
- Run by
- Takeda
See details and how to joinNCT06722235 · EU 2024-514401-54-00 - 1. fázisTaking peoplePhase IB open label, long-term, extension basket trial of RAY121 to inhibit classical complement pathway in immunological diseases (RAINBOW-LTE trial)
- Where
- Montpellier Cedex 5, Paris
- Életkor
- 18 év and over
- People
- 78 worldwide
- Run by
- Chugai Pharmaceutical Co. Ltd.
See details and how to join2024-511346-39-00 - 3. fázisTaking peopleA Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Where
- Creteil, Dijon
- Életkor
- 18 év and over
- People
- 150 worldwide
- Run by
- Takeda
See details and how to joinNCT06948318 · EU 2025-521692-31-00 - 2. fázisTaking peopleStudy to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
- Where
- Angers, Caen Cedex 9, Creteil Cedex, Dijon, Pessac, Toulouse, Vandoeuvre Les Nancy
- Életkor
- 18 év and over
- People
- 56 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07104565 · EU 2025-521286-27-00 - 2/3. fázisTaking peopleA Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
- Where
- Bordeaux, Grenoble Cedex 9, Nancy Cedex, Nantes
- Életkor
- 12 év to 17 év
- People
- 24 worldwide
- Run by
- argenx
See details and how to joinNCT07194850 · EU 2025-521055-23-00 - 1. fázisTaking peoplePhase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- Where
- Montpellier Cedex 5, Paris Cedex 13
- Életkor
- 18 év to 85 év
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06371417 · EU 2023-507692-21-00 - 1. fázisCsak meghívásosPhase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
- Where
- Montpellier, Paris
- Életkor
- 18 év to 85 év
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06723106 - No phaseNot yet taking people in FranciaországModeling the Early Stages of Autoimmunity Through the Study of Immunological Thrombocytopenic Purpura and Juvenile Lupus
- Where
- Bordeaux, Toulouse
- Életkor
- 1 év to 18 év
- People
- 105
- Run by
- University Hospital, Bordeaux
See details and how to joinNCT07680010 - No phaseTaking peopleContribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis
- Where
- Pessac
- Életkor
- 18 év and over
- People
- 225
- Run by
- University Hospital, Bordeaux
See details and how to joinNCT04800458 - 3. fázisTaking peopleA Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
- Where
- Amiens Cedex 1, Creteil, Dijon
- Életkor
- 18 év and over
- People
- 69 worldwide
- Run by
- argenx
See details and how to joinNCT06544499 · EU 2024-515451-38-00 - No phaseTaking peopleFrench Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia
- Where
- Toulouse
- Életkor
- 18 év and over
- People
- 1500
- Run by
- University Hospital, Toulouse
See details and how to joinNCT02877706 - No phaseNot yet taking people in FranciaországPhysical Fitness of Children, Adolescents and Young Adults With Immune Thrombocytopenic Purpura
- Where
- Montpellier, Palavas-les-Flots, Paris, Talence
- Életkor
- 8 év to 25 év
- People
- 53
- Run by
- University Hospital, Bordeaux
See details and how to joinNCT07310342 - No phaseTaking peopleBiological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia
- Where
- Pessac
- Életkor
- 18 év and over
- People
- 200
- Run by
- University Hospital, Bordeaux
See details and how to joinNCT04005638 - No phaseTaking peopleObservatory of Immunological Thrombopenic Purpura in the Brest Region
- Where
- Brest
- People
- 500
- Run by
- University Hospital, Brest
See details and how to joinNCT06556888 - 3. fázisTaking peopleEfficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia
- Where
- Amiens Cedex 1, Angers, Argenteuil Cedex, Avignon, Bois-Guillaume, Brest, Caen Cedex 9, Clamart, Clermont-Ferrand, Colmar Cedex, Corbeil-Essonnes, Creteil Cedex, Dijon, Dunkirk Cedex 1, La Roche Sur Yon Cedex 9, Le Kremlin-Bicetre, Lille Cedex, Lyon Cedex 04, Marseille, Nancy, Nantes, Paris, Paris Cedex 18, Périgueux, Pessac Cedex, Pierre-Bénite, Poitiers, Pringy Cedex, Quimper Cedex, Reims, Rennes, Saint Nazaire Cedex, Strasbourg Cedex, Suresnes, Toulouse
- Életkor
- 18 év and over
- People
- 132
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05338190 · EU 2024-516168-27-00 - No phaseTaking peopleOBS'CEREVANCE: French Cohort of Pediatric Autoimmune Cytopenia
- Where
- Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Paris, Quimper
- Életkor
- Up to 17 év
- People
- 3500
- Run by
- University Hospital, Bordeaux
See details and how to joinNCT05937828